122 results on '"Zhou, Youwen"'
Search Results
2. Characteristics of nitrogen and phosphorus contents in soil and water in an agricultural catchment of the three Gorges reservoir area
3. Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the International Vitiligo Task Force Part 1: towards a new management algorithm
4. Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the international Vitiligo Task Force—Part 2: Specific treatment recommendations
5. Vitiligo responds to topical aryl hydrocarbon receptor agonist tapinarof (WBI-1001)
6. Chafe et al Supplementary Materials and Methods from Targeting Hypoxia-Induced Carbonic Anhydrase IX Enhances Immune-Checkpoint Blockade Locally and Systemically
7. Chafe et al Supplementary Materials and Methods from Targeting Hypoxia-Induced Carbonic Anhydrase IX Enhances Immune-Checkpoint Blockade Locally and Systemically
8. Data from Targeting Hypoxia-Induced Carbonic Anhydrase IX Enhances Immune-Checkpoint Blockade Locally and Systemically
9. Data from Targeting Hypoxia-Induced Carbonic Anhydrase IX Enhances Immune-Checkpoint Blockade Locally and Systemically
10. Chafe et al Supplementary Data from Targeting Hypoxia-Induced Carbonic Anhydrase IX Enhances Immune-Checkpoint Blockade Locally and Systemically
11. Chafe et al Supplementary Data from Targeting Hypoxia-Induced Carbonic Anhydrase IX Enhances Immune-Checkpoint Blockade Locally and Systemically
12. Supplementary Figure 6 from Ectopic Expression of Cancer–Testis Antigens in Cutaneous T-cell Lymphoma Patients
13. Supplementary Table 1 from Ectopic Expression of Cancer–Testis Antigens in Cutaneous T-cell Lymphoma Patients
14. Supplementary Figure 2 from Ectopic Expression of Cancer–Testis Antigens in Cutaneous T-cell Lymphoma Patients
15. Supplementary Figure 5 from Ectopic Expression of Cancer–Testis Antigens in Cutaneous T-cell Lymphoma Patients
16. Data from The Use of Transcriptional Profiling to Improve Personalized Diagnosis and Management of Cutaneous T-cell Lymphoma (CTCL)
17. Supplementary Tables 1-4, Figure 1 from The Use of Transcriptional Profiling to Improve Personalized Diagnosis and Management of Cutaneous T-cell Lymphoma (CTCL)
18. Supplementary Figure 4 from Ectopic Expression of Cancer–Testis Antigens in Cutaneous T-cell Lymphoma Patients
19. Supplementary Figure 5 from Ectopic Expression of Cancer–Testis Antigens in Cutaneous T-cell Lymphoma Patients
20. Supplementary Figure 1 from Ectopic Expression of Cancer–Testis Antigens in Cutaneous T-cell Lymphoma Patients
21. Supplementary Tables 1-4, Figure 1 from The Use of Transcriptional Profiling to Improve Personalized Diagnosis and Management of Cutaneous T-cell Lymphoma (CTCL)
22. Supplementary Figure 7 from Ectopic Expression of Cancer–Testis Antigens in Cutaneous T-cell Lymphoma Patients
23. Supplementary Figure 6 from Ectopic Expression of Cancer–Testis Antigens in Cutaneous T-cell Lymphoma Patients
24. Supplementary Figure 1 from Ectopic Expression of Cancer–Testis Antigens in Cutaneous T-cell Lymphoma Patients
25. Supplementary Table 1 from Ectopic Expression of Cancer–Testis Antigens in Cutaneous T-cell Lymphoma Patients
26. Supplementary Figure 2 from Ectopic Expression of Cancer–Testis Antigens in Cutaneous T-cell Lymphoma Patients
27. Supplementary Figure 3 from Ectopic Expression of Cancer–Testis Antigens in Cutaneous T-cell Lymphoma Patients
28. Supplementary Figure 3 from Ectopic Expression of Cancer–Testis Antigens in Cutaneous T-cell Lymphoma Patients
29. Supplementary Figure 4 from Ectopic Expression of Cancer–Testis Antigens in Cutaneous T-cell Lymphoma Patients
30. Supplementary Figure 7 from Ectopic Expression of Cancer–Testis Antigens in Cutaneous T-cell Lymphoma Patients
31. Measuring h-index and scholarly productivity in academic dermatology in Canada
32. Evidence-Based Clinical Practice Guidelines for Extramammary Paget Disease
33. Guideline for the diagnosis, treatment and long-term management of cutaneous lupus erythematosus
34. Representation of sex, race, and ethnicity in pivotal clinical trials for dermatological drugs
35. Vitiligo Skin Biomarkers Associated With Favorable Therapeutic Response
36. Immunohistochemistry analysis reveals lysyl oxidase-like 3 as a novel prognostic marker for primary melanoma
37. Computer-Aided Discovery of Small Molecule Inhibitors of Thymocyte Selection-Associated High Mobility Group Box Protein (TOX) as Potential Therapeutics for Cutaneous T-Cell Lymphomas
38. Immunotherapy for Cutaneous T-Cell Lymphoma: Current Landscape and Future Developments
39. Targeting Hypoxia-Induced Carbonic Anhydrase IX Enhances Immune-Checkpoint Blockade Locally and Systemically
40. Existing and Emerging Therapies for Cutaneous T-Cell Lymphoma
41. Whole-Exome Sequencing Reveals Frequent Mutations in Chromatin Remodeling Genes in Mammary and Extramammary Paget’s Diseases
42. Acrodermatitis Continua of Hallopeau with Psoriatic Arthritis
43. A Vision for an Academic Career Mentorship Program for Canadian Dermatology Residents
44. Cytoplasmic Pin1 expression is increased in human cutaneous melanoma and predicts poor prognosis
45. IL-10 is overexpressed in human cutaneous T-cell lymphoma and is required for maximal tumor growth in a mouse model
46. Transcriptome analyses reveal FOXA1 dysregulation in mammary and extramammary Paget's disease
47. Drug Eruption to Rosuvastatin With Recurrence on Simvastatin: A Case Report
48. Polymorphisms and Pharmacogenomics for the Clinical Efficacy of Methotrexate in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-analysis
49. Polymorphisms and pharmacogenomics for the toxicity of methotrexate monotherapy in patients with rheumatoid arthritis
50. Cytokine Imbalance as a Common Mechanism in Both Psoriasis and Rheumatoid Arthritis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.